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Role of the Maillard Reaction in Aging of Tissue Proteins
ADVANCED GLYCATION END PRODUCT-DEPENDENT INCREASE IN IMIDAZOLIUM CROSS-LINKS
IN HUMAN LENS PROTEINS*
(Received for publication, February 3, 1998, and in revised form, May 4, 1998)
Elisabeth Brinkmann Frye‡, Thorsten P. Degenhardt‡, Suzanne R. Thorpe‡§,
and John W. Baynes‡§¶
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Carolina, Columbia, South Carolina 29208
Dicarbonyl compounds such as glyoxal and methyl-
glyoxal are reactive dicarbonyl intermediates in the
nonenzymatic browning and cross-linking of proteins
during the Maillard reaction. We describe here the
quantification of glyoxal and methylglyoxal-derived
imidazolium cross-links in tissue proteins. The imidazo-
lium salt cross-links, glyoxal-lysine dimer (GOLD) and
methylglyoxal-lysine dimer (MOLD), were measured by
liquid chromatography/mass spectrometry and were
present in lens protein at concentrations of 0.02–0.2 and
0.1–0.8 mmol/mol of lysine, respectively. The lens con-
centrations of GOLD and MOLD correlated significantly
with one another and also increased with lens age.
GOLD and MOLD were present at significantly higher
concentrations than the fluorescent cross-links pentosi-
dine and dityrosine, identifying them as major Maillard
reaction cross-links in lens proteins. Like the N-car-
boxy-alkyllysines Ne-(carboxymethyl)lysine and Ne-(car-
boxyethyl)lysine, these cross-links were also detected at
lower concentrations in human skin collagen and in-
creased with age in collagen. The presence of GOLD and
MOLD in tissue proteins implicates methylglyoxal and
glyoxal, either free or protein-bound, as important pre-
cursors of protein cross-links formed during Maillard
reactions in vivo during aging and in disease.
The Maillard reaction is a complex series of reactions be-
tween reducing sugars and amino groups on proteins, which
lead to browning, fluorescence, and cross-linking of protein (1,
2). Advanced glycation end products, formed during later
stages of the Maillard reaction, accumulate in long lived tissue
proteins, such as tissue collagens and lens crystallins, and may
contribute to the development of complications in aging, diabe-
tes, and atherosclerosis (3, 4). Glyoxal (GO),1 methylglyoxal
(MGO), and deoxyglucosones belong to a series of dicarbonyl
compounds, identified as intermediates in the Maillard reac-
tion. GO is formed on autoxidation of glucose under physiolog-
ical conditions (5) and also as a product of lipid peroxidation (6).
MGO is formed nonenzymatically by spontaneous decomposi-
tion of triose phosphate intermediates in glycolysis (7) and by
amine-catalyzed sugar fragmentation reactions (8, 9). It is also
a product of metabolism of acetone (10) and threonine (11).
Both GO and MGO are detoxified by the glutathione-dependent
glyoxalase pathway, yielding hydroxyacetic acid and D-lactate,
respectively (12–14). MGO can also be detoxified by the NADPH-
dependent enzyme aldose reductase, yielding 1,2-propanediol
(15). The concentration of MGO is elevated in the blood of
diabetic patients in vivo (16, 17), and the metabolites of MGO
detoxification, acetol and 1,2-propanediol, are also increased in
blood during diabetic ketoacidosis (10).
GO and MGO are reactive toward amino, guanidino, and
sulfhydryl functional groups in protein (18, 19), leading to
browning, denaturation, and cross-linking of proteins. Besides
unidentified brown and fluorescent products, the reaction of
GO and MGO with lysine and arginine residues in protein
yields well characterized compounds, such as the N-(carboxy-
alkyl)lysines, Ne-(carboxymethyl)lysine (CML) (20) and Ne-[1-
(1-carboxy)ethyl]lysine (CEL) (21), and imidazolones and dehy-
droimidazolones (19, 22, 23). Imidazolones have been detected
in tissue proteins only by immunological methods, whereas
CML and CEL have been measured by gas chromatography/
mass spectometry (GC/MS) and increase in skin collagen and
lens protein with age (21, 24–26). Two other products of the
reaction of GO or MGO with lysine, glyoxal-lysine dimer
(GOLD) and methylglyoxal-lysine dimer (MOLD) (Fig. 1), were
originally characterized in reactions of GO or MGO, respec-
tively, with hippuryllysine (27, 28). Nagaraj and colleagues (29)
recently detected and measured MOLD in human serum pro-
teins by reverse phase high performance liquid chromatogra-
phy assay (RP-HPLC) and showed that cross-linking of serum
proteins by MOLD was increased in diabetes. In the present
study, we describe the reaction of MGO with the model protein
bovine pancreatic RNase and quantify the role of MGO in
cross-linking of the protein. Using a liquid chromatography/
mass spectrometry (LC/MS) assay with 15N-labeled GOLD and
MOLD internal standards, we also measure the levels of GOLD
and MOLD in lens protein and show that the concentrations of
both cross-links increase in concert with chronological age in
lens protein and skin collagen. Quantitative analysis indicates
that MOLD is the major chemically characterized cross-link
formed in lens protein during the Maillard reaction.
EXPERIMENTAL PROCEDURES
Materials—Unless otherwise indicated, all chemical reagents were of
the highest quality obtainable from Sigma, including MGO (40% aque-
ous solution) and RNase A (type XII-A). (Carboxymethyl)trimethylam-
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DK-19971 from the NIDDK. The costs of publication of this article were
defrayed in part by the payment of page charges. This article must
therefore be hereby marked “advertisement” in accordance with 18
U.S.C. Section 1734 solely to indicate this fact.
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1 The abbreviations and trivial names used are: GO, glyoxal; CEL,
Ne-[1-(1-carboxy)ethyl]lysine; CML, Ne-(carboxymethyl)lysine; ESI,
electrospray ionization; RP-HPLC, reverse phase high performance liq-
uid chromatography assay; GOLD, glyoxal-lysine dimer, 1,3-di-(Ne-ly-
sino)imidazolium salt; HPLC, high performance liquid chromatogra-
phy; LC/MS, liquid chromatography/mass spectrometry; MGO,
methylglyoxal; MOLD, methylglyoxal-lysine dimer, 1,3-di-(Ne-lysino)-
4-methyl-imidazolium salt; PITC, phenylisothiocyanate; PTC, phenyl-
thiocarbamoyl; RNase, bovine pancreatic ribonuclease A; PAGE, poly-
acrylamide gel electrophoresis; GC/MS, gas chromatography/mass
spectrometry; SIM, selected ion monitoring; amu, atomic mass units.
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monium chloride hydrazide (Girard’s Reagent T) was obtained from
Aldrich. SupelClean LC-18 cartridges were obtained from Supelco
(Bellefonte, PA), and C-18 preparative material was obtained from the
Waters Corporation (Milford, MA). 15N2-L-LysinezHCl was obtained
from Cambridge Isotope Laboratories Inc. (Andover, MA).
Reaction of Na-Hippuryllysine with MGO—For identification of prod-
ucts formed in reactions of MGO with the e-amino groups of lysine,
mixtures of 100 mM hippuryllysine and 100 or 200 mM MGO were
incubated in 0.2 M phosphate buffer at pH 7.4 and 37 °C. Aliquots were
removed at various time points and analyzed by RP-HPLC.
Preparative Procedures—MOLD and GOLD were prepared by incu-
bating 100 mM hippuryllysine with 200 mM MGO or GO in aqueous 200
mM formaldehyde. The reaction of MGO and hippuryllysine was con-
ducted at 37 °C, and the reaction of GO and hippuryllysine was con-
ducted at 65 °C. Additional MGO or GO (100 mM) and formaldehyde
(100 mM) were added 8 times at hourly intervals and the reaction
continued overnight. The pH dropped from 6 initially to 2.5 at the end
of the reaction. The solutions were applied to a 0.75 3 10-cm column of
C-18 preparative resin and eluted with a gradient of increasing concen-
trations of acetonitrile in water. Fractions were analyzed for absorb-
ance at 228 nm, and those containing hippuryl-MOLD or -GOLD, de-
tected by RP-HPLC, were pooled, dried, and finally cleaned by semi-
preparative HPLC, using the analytical RP-HPLC system described
below. To obtain free MOLD or GOLD, the hippuryl group was removed
by hydrolysis in 6 N HCl for 4 h at 110 °C.
For preparation of the heavy labeled cross-links 15N4-MOLD and
15N4-GOLD,
15N2-L-N
a-formyllysine (100 mM), prepared from 15N2-L-
lysine as described by Hofmann et al. (30), was incubated with MGO or
GO (200 mM) and formaldehyde (200 mM) in deionized water. The
reactions were conducted for 30 h as described above. Deformylated
MOLD and GOLD were obtained by hydrolysis in 6 N HCl for 2 h at
110 °C. The hydrolysate was dried by centrifugal evaporation (Speed-
Vac, Savant Instruments, Holbrook, NY) and reconstituted in water,
and brown products were removed by applying the product to a Supel-
clean-LC18 column (3 ml) in water. The yield determined by cation
exchange chromatography was approximately 60% for 15N4-MOLD and
50% for 15N4-GOLD.
Reaction of RNase with MGO—RNase (20 mg/ml, 1.5 mM) was incu-
bated with MGO (15 or 30 mM MGO at molar ratios to lysine of 1:1 or
2:1, respectively) in 0.2 M phosphate buffer, pH 7.4, at 37 °C. Aliquots
were removed at various times and reduced with NaBH4 as described
above. After quenching the reaction with acetic acid, the reduced pro-
tein was dialyzed against deionized water, concentrated by centrifugal
evaporation, and hydrolyzed in 6 N HCl at 110 °C for 22 h. The hydro-
lyzed protein was dried and applied to a Supelclean LC-18 column (1
ml) to remove brown products. The dried protein, dissolved in 5 ml of
deionized water, was applied to sulfopropyl-cation exchange gel (SP-
Sephadex C-25; 1.2 ml). Neutral and acidic amino acids were eluted
with 25 ml of 0.05 N HCl and basic amino acids, including MOLD, with
7 ml of 1 N HCl. For phenylisothiocyanate (PITC) derivatization, the
sample was dried, dissolved in 30 ml of coupling buffer (water:ethanol:
triethylamine, 2:2:1), and dried. PITC derivatization was conducted
with 50 ml of a mixture of ethanol, water, triethylamine, and PITC
(7:1:1:1) as described by Bidlingmeyer et al. (31). The derivatization
mixture was evaporated by centrifugal evaporation, and the residue
was dissolved in deionized water. Excess derivatization reagent was
extracted with n-heptane, discarding the organic layer. The phenylthio-
carbamoyl (PTC) amino acids were dissolved in solvent A for RP-HPLC.
Histidine, which was unaltered during reaction of the protein with
MGO and was recovered quantitatively during this procedure, was used
as the internal standard for quantitation of Lys, Arg, and MOLD.
HPLC Procedures—Amino acid analysis was performed using a Pick-
ering sodium cation exchange column (25 cm 3 4.6 mm) and sodium
buffers (Pickering Laboratories Inc., Mountain View, CA), as described
by the manufacturers. Amino acids were quantified by post-column
derivatization with o-phthalaldehyde and fluorescence detection (20,
32). Hippuryl-amino acids were analyzed by RP-HPLC either on a 25
cm 3 4.6 mm Zorbax SB C-18 HPLC column (MAC-MOD Analytical
Inc., Chadds Ford, PA) or on a 15 cm 3 3 mm-Waters C-18 Symmetry
column (Waters Corporation) using a detection wavelength of 228 nm.
The gradient consisted of solvent A (0.05% acetic acid, 0.05% formic
acid, and 0.1% triethylamine in water) and solvent B (75% solvent A in
acetonitrile). The gradient program for the Zorbax column was: 0–50
min, 0–5% solvent B; 50–160 min, 5–100% solvent B; 160–190 min,
wash with 100% acetonitrile, at a flow rate of 1 ml/min; and for the
Symmetry column: 0–30 min, 0–10% solvent B; 30–100 min, 10–100%
solvent B; 100–105 min, wash with 100% acetonitrile, at a flow rate of
0.5 ml/min. PTC amino acids were analyzed on a 15 cm 3 4.6 mm-inner
diameter 218TP54 protein and peptide C-18 column (VYDAC/The Sep-
arations Group, Hesperia, CA) using a detection wavelength of 246 nm.
The mobile phase consisted of solvent A (12.5 mM sodium phosphate, pH
6.2) and solvent B (30% solvent A and 70% acetonitrile). The gradient
was programmed as follows: 0–2 min, 0% solvent B; 2–40 min, 0–50%
solvent B; 40–50 min, 50–100% solvent B; this was followed by a
10-min washing step with 100% acetonitrile, flow rate 1.2 ml/min.
Measurement of MGO Concentrations—MGO was measured using
Girard’s Reagent T in 0.5 M formic acid, pH 2.9, as described by Mitchel
and Birnboim (33), using absorbance at 292 nm for quantitation.
Electrophoresis—SDS-PAGE was conducted under reducing condi-
tions using a 4% stacking gel and a 15% separating gel as described by
Laemmli (34).
Preparation of Human Lens Protein and Skin Collagen for Analysis
of MOLD and GOLD—Human lenses were obtained from the South
Carolina Lions Eye Bank (Columbia, SC) and stored at 270 °C until
used. Lenses were decapsulated, homogenized and dialyzed against
deionized water, as described previously (26, 35). Total lens protein was
hydrolyzed in 6 N HCl at 110 °C for 24 h. The hydrolysate was dried and
then applied to an SP-Sephadex cation exchange resin to recover basic
amino acids, washed, and eluted, as described above. The eluent was
dried by centrifugal evaporation and reconstituted in buffer A (sodium
eluent, pH 3.15) for amino acid analysis. Fractions in the time interval
including lysine, MOLD, and GOLD (15–25 min, 6 ml total volume)
were collected. These pools were diluted with deionized water to 50 ml,
acidified with 4 N HCl to pH 1–2, applied to a 2 ml-DOWEX-50W cation
(sodium form), and desalted by washing with 70 ml of 0.5 N HCl; then
the basic amino acids were eluted with 4 N HCl. The eluent was dried
and derivatized for PTC amino acid analysis as described above.
Human skin collagen was isolated by full thickness biopsy from the
upper buttock, as described previously in detail (24). Briefly, the skin
was scraped to remove adventitious tissue, extracted sequentially for
24 h with 1 M NaCl in 10 mM phosphate buffer, pH 7.4, and with 0.5 M
acetic acid to remove soluble proteins, and then extracted with chloro-
form:methanol (2:1) to remove any residual lipid. The collagen was
hydrolyzed and analyzed as described above for lens proteins.
LC/MS Analysis of GOLD and MOLD in Human Lens Proteins and
Skin Collagen—For LC/MS analysis about 2 mg of lens protein was
mixed with 3 nmol of 15N4-MOLD and 2.5 nmol of
15N4-GOLD or 4 mg
of young (18 years) and old (85 years) pools of human skin collagen with
1.5 nmol of 15N4-MOLD and 1.25 nmol of
15N4-GOLD. The samples were
hydrolyzed, processed, and derivatized with PITC, as described above.
Gradient HPLC/MS analysis was performed using a 100 3 1-mm Hy-
persil ODS column (Keystone Scientific Inc., Bellefonte, PA) with a 2 3
1-mm guard column. The gradient consisted of solvent A (90% water,
10% methanol, and 0.3% glacial acetic acid) and solvent B (20% water,
80% methanol, and 0.3% glacial acetic acid). The gradient was: 100%
solvent A for 5 min, then to 100% solvent B at 15 min, and hold at 100%
solvent B for 20 min; the flow rate was 50 ml/min. The ion source was an
Analytica of Branford Inc. electrospray model 103443 (Branford, CT),
operating with the following settings: cylinder voltage, 22600 V; end
cap voltage, 23700 V; capillary voltage, 24800 V; current, 4 3 1028 A;
source temperature, 275 °C; needlegas pressure, 38 p.s.i.; lens 1–6
voltages, 147.8, 25.6, 25.4, 2.7, 0, and 249.1 V. The mass spectrometer
was a VG TRIO triple quadrupole mass analyzer (Beverly, MA) oper-
ating at: dwell time, 150 ms; delay time, 20 ms; and photomultiplier
voltage, 600 V. The masses monitored were 417 amu for PTC-Lys1H1,
597 amu for (PTC)2-GOLD, 601 amu for (PTC)2-
15N4-GOLD, 611 amu
FIG. 1. Products of the reaction of glyoxal and methylglyoxal
with lysine residues in protein.

























for (PTC)2-MOLD, and 615 amu for (PTC)2-
15N4-MOLD. All assays were
analyzed in a single batch to exclude interassay variation. Results of
single analyses of each sample are shown. The intra-assay coefficients
of variation for assay of GOLD and MOLD, measured at the mid-range
of the samples, were 14 and 12%, respectively (n 5 5).
RESULTS
Characterization of Imidazolium Cross-links—As reported
previously, GOLD and MOLD were originally isolated from
reactions of GO or MGO, respectively, with the model peptide
Na-hippuryllysine (27, 28). RP-HPLC analysis of reactions of
MGO with hippuryllysine (MGO:Lys, 2:1) yielded two major
products (Fig. 2A) subsequently identified as Na-hippuryl-CEL
and (Na-hippuryl)2-MOLD. Acid hydrolysis and amino acid
analysis also yielded two major products, CEL and MOLD (Fig.
2B). The identity of CEL was confirmed by its elution time on
HPLC analysis and by GC/MS analysis of its trifluoroacetyl
methyl ester derivative (M1 5 438 amu) (21). ESI mass spec-
trometry was used for identification of (Na-hippuryl)2-MOLD
and MOLD (M1 5 663 and 341 amu, respectively, before and
after acid hydrolysis) (28). Yields were ;12% CEL and ;32%
MOLD, based on original Na-hippuryllysine. Similar results
were obtained from reactions of GO with Na-hippuryllysine,
yielding ;33% CML and ;32% GOLD (27) (data not shown). In
numerous reactions of GO or MGO with Na-hippuryllysine or
proteins (RNase or albumin) at a variety of concentration ra-
tios, both carboxyalkyllysines and imidazolium salt compounds
were always formed together. Yields and relative yields varied
with absolute concentrations and concentration ratios, as de-
scribed for RNase in Fig. 3. Browning was more rapid and
intense in reactions containing MGO, indicating a higher yield
of melanoidins from MGO, compared with GO.
Formation of Imidazolium Cross-links during the Reaction of
MGO with RNase—Because MGO is present in higher concen-
trations in biological systems than GO (14), we concentrated on
the reactions of MGO with protein. Reactions of MGO with the
model protein RNase were studied under physiological condi-
tions (pH 7.4, 37 °C). MGO was reacted with RNase, which has
10 lysine residues, at molar ratios of MGO:Lys, 1:1 and 2:1. As
shown in Fig. 3, MOLD was readily detectable in MGO- mod-
ified RNase by RP-HPLC of the PTC derivative. The identity of
the MOLD was confirmed by co-elution with an authentic
standard and by its molecular mass of (PTC)2-MOLD (611
amu) measured by ESI-MS. The kinetics of the formation of
MOLD described in Fig. 4A were consistent with the kinetics of
the disappearance of MGO from the reaction mixture (Fig. 4B).
The half-life of MGO in the presence of the protein was ;4 h at
both concentrations, whereas in phosphate buffer alone it dis-
appeared with a half-life of ;30 h (Fig. 4B). The yield of MOLD
increased 4–5-fold on doubling of the MGO concentration, an
observation confirmed in two independent experiments, con-
sistent with either a rate-limiting second order process or the
requirement for 2 mol of MGO/mol of MOLD formed. In con-
trast, lysine and arginine decreased to similar extents at both
MGO concentrations, yielding maximal modification of 5–6 of
10 lysine and 3 of 4 arginine residues in RNase (Fig. 4, C and
D). The possibility that some free lysine and arginine were
generated during acid hydrolysis cannot be excluded; however,
the extent of the lack of reactivity of 3–4 lysine residues was
confirmed by reaction with trinitrobenzenesulfonic acid (data
not shown). Although $50% of lysine residues were modified in
these reactions with formation of 20 or 95 mmol MOLD, only 1
or 3.6%, respectively, of the lysine loss could be accounted for as
MOLD. CEL, measured by GC/MS (data not shown), accounted
for an additional 1.3 or 1.6% of the total lysine modification
(21). Thus, MOLD and CEL accounted for #5% of the modifi-
cation of lysine residues in the protein. Browning, cross-link-
ing, and formation of fluorescent products also occurred, indi-
cating that other unidentified products were formed. As shown
in Fig. 5, the time course of cross-linking of RNase, estimated
by SDS-PAGE, was consistent with the rate of formation of
MOLD (Fig. 4A).
MGO-modified RNase was fractionated into monomer,
FIG. 2. Chromatographic identification of MOLD in the reac-
tions of MGO with Na-hippuryllysine. A, RP-HPLC chromatogram
of a reaction mixture of 200 mM MGO and 100 mM hippuryllysine in 200
mM phosphate buffer for 24 h at 37 °C. Products were identified as
Na-hippuryl-CEL and (Na-hippuryl)2-MOLD (73 and 120 min, respec-
tively). B, cation exchange amino acid analysis of the same reaction
mixture after acid hydrolysis (6 M HCl, 24 h at 110 °C). Products were
detected by fluorescence following reaction with o-phthalaldehyde (20,
32). CEL (24 min) eluted in the region of isoleucine-methionine and
MOLD (58 min) as a basic amino acid.
FIG. 3. Detection of MOLD in MGO-modified RNase by RP-
HPLC. RNase was incubated with MGO (MGO:Lys 5 2:1) in 0.2 M
phosphate buffer, pH 7.4, for 24 h at 37 °C. Basic amino acids were
isolated from the protein hydrolysate by chromatography on SP-Seph-
adex as described under “Experimental Procedures” and then deriva-
tized with PITC for HPLC analysis. The inset shows the enlarged view
of the elution time frame of MOLD.

























dimer, and polymer by chromatography on Sephadex G-75 (Fig.
6). Fractions were pooled, as indicated in the figure, and then
analyzed for their MOLD content. As shown in the inset to Fig.
6, the MOLD content of RNase increased with the extent of
polymerization of the protein. These data indicate that MOLD
contributes to both inter- and intramolecular cross-linking of
lysine residues in RNase; however, the yield of MOLD in the
RNase dimer fraction (Fig. 6, inset) accounted for only about 5%
of intermolecular cross-links, indicating that other cross-links
were also formed.
Detection of MOLD and GOLD in Vivo— Human lens pro-
teins were analyzed for their MOLD and GOLD content using
the RP-HPLC analytical procedure described in Fig. 3. The lens
proteins were analyzed as a function of age, because both CEL
and CML accumulate in these proteins with age (21, 26). As
shown in Fig. 7, both MOLD and GOLD were detectable by
RP-HPLC in the hydrolysate of lens protein. The peak identi-
ties were confirmed by co-elution with an authentic standard,
but the reliability of the assay was questionable because of the
low levels of MOLD and GOLD in lens proteins and their
possible co-elution with other trace compounds in protein. To
obtain more reliable results, we applied an LC/MS procedure to
analyze lens protein hydrolysates that were derivatized with
PITC. Heavy labeled MOLD and GOLD were prepared from
15N2-lysine for use as internal standards. Nonlabeled PTC2-
MOLD and PTC2-GOLD were detected at the masses 611 and
597 amu, respectively, and their heavy labeled counterparts at
615 and 601 amu, respectively. Fig. 8 shows an RP-HPLC/SIM-
ESI chromatogram of PITC-derivatized lens protein, confirm-
ing detection of both GOLD and MOLD in lens protein. The
standard curves (inset) were prepared by adding increasing
amounts of natural GOLD and MOLD to a fixed amount of
internal standard.
Using internal standardization with heavy labeled MOLD
and GOLD, these compounds were measured in a group of lens
proteins by HPLC-ESI-SIM-MS. As shown in Fig. 9, both
MOLD and GOLD correlated significantly with age in human
lens protein (r2 5 0.69 and 0.75, respectively; p , 0.001). The
MOLD and GOLD content of lens protein also correlated with
FIG. 4. Kinetics of the reaction of MGO with RNase. MGO and
RNase were incubated in 0.2 M phosphate buffer, pH 7.4, at molar ratios
of MGO:Lys, 1:1 (f) or 2:1 (●), respectively. MOLD, lysine, and arginine
were measured as their PTC derivatives. MGO was measured using
Girard’s Reagent T. A, kinetics of the formation of MOLD; B, kinetics of
the consumption of MGO at MGO:Lys, 2:1 (●) and at the same concen-
tration in phosphate buffer in absence of RNase (E). C and D, kinetics
of the modification of lysine and arginine residues in RNase.
FIG. 5. SDS-PAGE analysis of cross-linking of RNase during
reaction with MGO. Lanes 1 and 9, molecular mass markers, cyto-
chrome c (12,400 Da), carbonic anhydrase (29,000 Da), bovine serum
albumin (66,000 Da), and alcohol dehydrogenase (150,000 Da); lane 2,
native RNase; lanes 3–8, RNase, reacted with MGO (MGO:Lys, 1:1) at
0, 1, 2, 8, 48, and 96 h.
FIG. 6. Gel permeation chromatography of RNase following
reaction with MGO. RNase was pooled from reactions with MGO at
18 h, as described in Fig. 4, and then applied to a Sephadex G-75 column
(75 3 1.5 cm; 18 mg of protein). The column was eluted with phosphate-
buffered saline, and fractions of 1.7 ml were collected. The protein was
pooled into monomer, dimer, and trimer fractions, as shown. Aliquots of
these pools were hydrolyzed and analyzed by RP-HPLC as described
above. Results of analyses are shown in the table (inset).
FIG. 7. Detection of imidazolium cross-links in human lens
proteins by RP-HPLC. Basic amino acids were isolated by cation
exchange chromatography then derivatized with PITC and analyzed by
RP-HPLC. MOLD was identified by co-elution of an authentic standard.
Trace levels of GOLD were also detectable in lens proteins.

























each other (r2 5 0.69, p , 0.001). The concentration of MOLD
in lens protein was approximately 5 times higher on average
than that of GOLD. Measurements of MOLD in lens protein,
determined by the LC/MS assay, were consistent with the
results of RP-HPLC analysis, as described in Fig. 7, but con-
centrations measured by LC/MS were 25–80% of those esti-
mated by RP-HPLC, consistent with errors in quantification or
interference by co-eluting compounds in the HPLC assay.
GOLD could not be measured in lens proteins by HPLC alone.
In preliminary experiments, MOLD and GOLD were also
detected in human skin collagen. Traces of both cross-links
(,0.02 mmol/mol of Lys) were detectable in a pool of collagen
from young donors (18 years old), but MOLD and GOLD were
present at concentrations of 0.38 and 0.04 mmol/mol of Lys,
respectively, in a pool from older donors (85 years old). The
lower level of cross-links in collagen is consistent with the
correspondingly lower levels of CML and CEL in skin collagen,
compared with lens proteins (21, 24).
DISCUSSION
In these and other studies, we have identified CML and
GOLD (27) and CEL and MOLD (28) as products of the reaction
of GO and MGO with hippuryllysine and with RNase, respec-
tively. Our studies on reactions with MGO confirm the obser-
vations of Nagaraj et al. (29) who described the formation of an
MGO-derived imidazolium cross-link (MOLD, imidazolysine)
in model systems and detected MOLD in human serum pro-
teins by an HPLC method. Skovsted et al. (36) have also de-
scribed another imidazolium cross-link, termed DOLD, which
is formed by reaction of 3-deoxyglucosone with protein, al-
though this compound has not yet been detected in tissue
proteins. Dicarbonyl compounds, such as GO, MGO, and 3-de-
oxyglucosone, are also known to form imidazolones and dehy-
droimidazolones on reaction with arginine residues in proteins
(19, 22, 23); however, the relative reactivity of Lys and Arg
residues with dicarbonyl compounds has not been rigorously
evaluated, in part because of the lack of appropriately sensitive
and specific analytical methods for (dehydro)imidazolones.
In the present study, we describe an LC/MS assay for spe-
cific, accurate, and simultaneous measurement of both MOLD
and GOLD in tissue proteins and show that both compounds
increase in concert with one another in human lens protein
during normal aging. Levels of MOLD measured by this tech-
nique were significantly lower than levels measured by HPLC
alone, undoubtedly because of the greater specificity of the
HPLC-ESI-SIM-MS technique, and in our hands, the HPLC
technique was not reliable for estimation of the lower concen-
trations of GOLD in tissue proteins. MOLD and GOLD to-
gether account for only 0.2% of chemical modification of lysine
residues in a senescent lens (;0.2 mmol of GOLD 1 0.8 mmol
of MOLD/mol of Lys at age 80 3 2 mol of Lys/cross-link). In
contrast CML and CEL are present at nearly 10-fold higher
concentrations (;4 mmol of CML 1 4 mmol of CEL/mol of
lysine), representing 0.8% of lysine modification (21). Regard-
less of their low concentrations, MOLD and GOLD are present
at significantly higher concentrations in lens proteins than the
fluorescent cross-links pentosidine and dityrosine. At age 80,
MOLD, GOLD, pentosidine, and dityrosine represent approxi-
mately 800, 200, 4, and 3 mmol/mol of lysine in lens protein (37,
38). In our 85-year-old skin collagen pool, MOLD and GOLD
are present at 400 and 40 mmol/mol lysine, respectively, com-
pared with 40 mmol pentosidine/mol lysine (24). At 100 mol of
Lys/mol of triple stranded collagen, MOLD is present at 0.04
FIG. 8. Determination of MOLD and GOLD in human lens pro-
teins by LC/MS. Heavy labeled standards were added to lens protein
prior to acid hydrolysis. The protein was hydrolyzed, basic amino acids
isolated, and amino acid derivatized with PITC, as described under
“Experimental Procedures.” Using HPLC-ESI-MS, the masses recorded
were 597 amu for GOLD, 601 amu for 15N4-GOLD, 611 amu for MOLD,
and 615 for 15N4-MOLD. Standard curves were prepared by adding
known amounts of GOLD and MOLD (597 and 611 amu) to constant
amounts of internal standards (601 and 615 amu) (insets).
FIG. 9. MOLD (A) and GOLD (B) increase in human lens pro-
tein with age.

























mol/mol of collagen (0.08% of lysine residues). In contrast,
enzymatically formed cross-links are much more abundant
(1–5 mol/mol of collagen) (39). Thus, it is unlikely that GOLD or
MOLD would have a significant impact on collagen cross-link-
ing in aging, unless they are present at critical sites in the
collagen molecule.
Our proposed mechanism for imidazolium cross-link forma-
tion includes the initial reaction of the dicarbonyl with two
lysine molecules forming a labile Schiff base, diimine cross-
link, and then recruitment of a second molecule of MGO for the
cyclization reaction (27, 28). Glomb and Monnier (40) have
described the formation of a diimine structure in reactions of
protein with GO in vitro. Yim et al. (41) also propose that the
reaction of dicarbonyls with amino groups yields radical inter-
mediates, including a dicarbonyl dialkylamine radical cation
and a dicarbonyl radical anion, which then react to form the
stable advanced glycation end products. Although it is possible
that GOLD and MOLD were among the major advanced glyca-
tion end products formed in these and our in vitro studies in the
presence of an excess of dicarbonyl compounds, it is likely that
in biological systems at low GO and MGO concentrations, other
aldehydes, including formaldehyde, acetaldehyde, glucose, or
glycolytic intermediates would serve as carbon donors for the
cyclization reaction. Thus, the pathway to formation of GOLD
and MOLD in vivo may be unusually complex and difficult to
unravel. As we and others have shown, there are many possible
routes and precursors of CML and CEL in vitro (5, 21, 37, 40,
42), and it is possible that other precursors, e.g. ascorbate or
polyunsaturated fatty acids in lipids, are more significant
sources of GOLD and MOLD in vivo.
In our studies on the cross-linking of RNase by MGO, we
show that MOLD is involved in both intermolecular and in-
tramolecular cross-linking reactions. MOLD accounts for only a
small percentage (;5%) of the cross-links in the dimer fraction
of RNase (Fig. 6), indicating that there are other unidentified
cross-links, possibly involving amino acids other than lysine.
The ratio of carboxyalkyllysines:imidazolium salts and of in-
tramolecular:intermolecular cross-links by imidazolium salts
undoubtedly varies with protein structure and the packing
density of protein monomers. RNase has three lysine residues
(1, 7, 41) clustered in or near the active site of the protein,
which are also major sites for modification of the protein by
glucose (43). The adjacency of these lysine amino groups may
favor intramolecular cross-linking of the protein. In other pro-
teins, glycation occurs preferably at lysine-lysine sequences
(44), which should favor intramolecular cross-linking, or at
lysine residues in other basic amino acid sequences (45, 46) and
at lysine residues apposed to acidic amino acids (46, 47), which
may favor intermolecular cross-linking. Proteins on membrane
surfaces, which are packed more densely than soluble proteins,
may also be more susceptible to intermolecular cross-linking
reactions. The close packing may also accelerate the age-de-
pendent, intermolecular cross-linking, aggregation, and insolu-
bilization of lens proteins during the Maillard reaction. Studies
on the distribution of GOLD and MOLD in various lens protein
fractions and on the specificity of carboxyalkylation and cross-
linking of proteins by GO and MGO should provide insight into
the role of these reactions in alteration of tissue proteins in
aging and disease.
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